These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19036936)

  • 1. Identification of plasmid-mediated AmpC beta-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results.
    Tenover FC; Emery SL; Spiegel CA; Bradford PA; Eells S; Endimiani A; Bonomo RA; McGowan JE
    J Clin Microbiol; 2009 Feb; 47(2):294-9. PubMed ID: 19036936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species.
    Kohner PC; Robberts FJ; Cockerill FR; Patel R
    J Clin Microbiol; 2009 Aug; 47(8):2419-25. PubMed ID: 19494061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.
    Song W; Jeong SH; Kim JS; Kim HS; Shin DH; Roh KH; Lee KM
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):315-8. PubMed ID: 17174510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY; Ng SY; Teo L; Koh Y; Teok CH
    J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the MicroScan NegCombo panel Type 44 for detection of extended-spectrum beta-lactamase among clinical isolates of Escherichia coli, Klebsiella species, and Proteus mirabilis].
    Ko SY; Chung JW; Song AJ; Yoon NS; Sung H; Kim MN
    Korean J Lab Med; 2009 Feb; 29(1):35-40. PubMed ID: 19262076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
    Coşkun S; Altanlar N
    Mikrobiyol Bul; 2012 Jul; 46(3):375-85. PubMed ID: 22951650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis.
    Coudron PE
    J Clin Microbiol; 2005 Aug; 43(8):4163-7. PubMed ID: 16081966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of bla
    Rizi KS; Mosavat A; Youssefi M; Jamehdar SA; Ghazvini K; Safdari H; Amini Y; Farsiani H
    J Glob Antimicrob Resist; 2020 Sep; 22():477-482. PubMed ID: 32247080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut.
    Tenover FC; Mohammed MJ; Gorton TS; Dembek ZF
    J Clin Microbiol; 1999 Dec; 37(12):4065-70. PubMed ID: 10565933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students.
    Chirindze LM; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Sundsfjord A; Essack SY; Simonsen GS
    BMC Infect Dis; 2018 May; 18(1):244. PubMed ID: 29843632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China.
    Ding H; Yang Y; Lu Q; Wang Y; Chen Y; Deng L; Wang A; Deng Q; Zhang H; Wang C; Liu L; Xu X; Wang L; Shen X
    Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):915-21. PubMed ID: 18449580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
    Tofteland S; Dahl KH; Aasnæs B; Sundsfjord A; Naseer U
    Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of AmpC beta-lactamase and extended spectrum beta-lactamase co-producer in Escherichia coli and Klebsiella species in a teaching hospital.
    Ting SMV; Ismail Z; Hanafiah A
    Malays J Pathol; 2024 Apr; 46(1):79-89. PubMed ID: 38682847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan.
    Yamasaki K; Komatsu M; Abe N; Fukuda S; Miyamoto Y; Higuchi T; Ono T; Nishio H; Sueyoshi N; Kida K; Satoh K; Toyokawa M; Nishi I; Sakamoto M; Akagi M; Nakai I; Kofuku T; Orita T; Wada Y; Jikimoto T; Kinoshita S; Miyamoto K; Hirai I; Yamamoto Y
    J Clin Microbiol; 2010 Sep; 48(9):3267-73. PubMed ID: 20610688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.